Annals of the Rheumatic Diseases
Abbreviated title (ISO 4)
|Ann. Rheum. Dis.|
|Edited by||Tore K. Kvien|
|Delayed, after 12 months|
The Annals of the Rheumatic Diseases is a peer-reviewed medical journal. It is co-owned by the BMJ Group and the European League Against Rheumatism and covers all aspects of rheumatology, including musculoskeletal conditions, arthritis, and connective tissue diseases. The journal publishes basic, clinical, and translational research and abstracts from conferences. The journal was established in 1939. It is available online by subscription and archived editions of the journal (older than one year) are available free of charge. Each issue, the editor-in-chief selects a paper to be published open access as an "Editors Choice". The editor-in-chief is Tore K. Kvien.
The journal publishes lay summaries for patients and non-clinicians that explain the findings and treatment implications arising from key research papers published in the journal. Written by BMJ's Best Health team, they are also checked for accuracy by the journal's editors.
Abstracting and indexing
The journal is abstracted and indexed by the Science Citation Index, Index Medicus, Excerpta Medica, and BIOSIS Previews. According to the Journal Citation Reports, its 2014 impact factor is 10.377 ranking it first out of 32 journals in the category "Rheumatology".
The Annals of the Rheumatic Diseases has been cited most often by: Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Rheumatology, Journal of Rheumatology, and Clinical and Experimental Rheumatology. The journals that have been cited most by Annals of the Rheumatic Diseases are Arthritis & Rheumatism, Annals of the Rheumatic Diseases, Journal of Rheumatology, Rheumatology, and Journal of Immunology.
- Journal homepage
- "Journals Ranked by Impact: Rheumatology". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.